OncoGenex Pharmaceuticals, Inc. Message Board

I still think MDVN provides the best road map for OGXN. MDVN had 3 solid weeks following enrollment completion announcement and a new trend was started it does not take a lot of dough to move this name in either direction the shorts have been reducing their exposure and this is a positive sign IMO as they are usually better informed than you and me.

I heard the same - something to do with ability of ASO drugs to cross blood brain barrier. Extent of my knowledge. I hope all is well Howard. Lets hope this stock creeps up in 2013.